HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paul Schaefer Selected Research
Paul Schaefer Research Topics
Disease
7
Neoplasms (Cancer)
11/2016 - 07/2003
4
Colonic Neoplasms (Colon Cancer)
02/2012 - 06/2008
2
Urticaria (Hives)
06/2023 - 06/2017
2
Chronic Urticaria
06/2017 - 05/2011
2
Pancreatic Neoplasms (Pancreatic Cancer)
11/2016 - 03/2008
2
Residual Neoplasm
03/2013 - 08/2011
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2013 - 08/2011
2
Leukemia
03/2013 - 08/2011
2
Infections
12/2012 - 03/2008
2
Microsatellite Instability
12/2009 - 06/2008
2
Colorectal Neoplasms (Colorectal Cancer)
12/2009 - 06/2008
1
Angioedema
06/2023
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
03/2013
1
Carcinogenesis
02/2012
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2011
1
Adenocarcinoma
03/2008
1
Febrile Neutropenia
03/2008
1
Glioma (Gliomas)
09/2007
1
Dementia (Dementias)
01/2005
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2005
1
Cognitive Dysfunction
01/2005
1
Breast Neoplasms (Breast Cancer)
07/2003
Drug/Important Bio-Agent (IBA)
3
Fluorouracil (Carac)
FDA Link
Generic
02/2012 - 03/2008
2
Immunoglobulin E (IgE)
IBA
06/2023 - 06/2017
2
Histamine (Histamine Dihydrochloride)
FDA Link
06/2023 - 06/2017
2
Proteins (Proteins, Gene)
FDA Link
11/2016 - 06/2008
2
Gemcitabine
FDA Link
11/2016 - 03/2008
2
Leucovorin (Folinic Acid)
FDA Link
02/2012 - 12/2009
2
Irinotecan (Camptosar)
FDA Link
Generic
02/2012 - 12/2009
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
06/2017
1
Omalizumab (Xolair)
FDA Link
06/2017
1
Equilibrative Nucleoside Transporter 1
IBA
11/2016
1
Natalizumab (Tysabri)
FDA Link
03/2013
1
nilotinib
FDA Link
03/2013
1
Integrin alpha4
IBA
03/2013
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2012
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
02/2012
1
Inhibitor of Apoptosis Proteins
IBA
08/2011
1
Survivin
IBA
08/2011
1
Small Interfering RNA (siRNA)
IBA
08/2011
1
Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)
IBA
05/2011
1
Histamine H1 Antagonists
IBA
05/2011
1
Cetuximab (Erbitux)
FDA Link
12/2009
1
ErbB Receptors (EGF Receptor)
IBA
12/2009
1
Panitumumab (Vectibix)
FDA Link
12/2009
1
Indicators and Reagents (Reagents)
IBA
07/2009
1
Vitamin E
FDA Link
Generic
01/2005
1
Donepezil (Aricept)
FDA Link
Generic
01/2005
1
Ceramides
IBA
07/2003
1
Sphingolipids
IBA
07/2003
Therapy/Procedure
6
Drug Therapy (Chemotherapy)
03/2013 - 09/2007
5
Therapeutics
03/2013 - 01/2005
4
Adjuvant Chemotherapy
02/2012 - 06/2008
1
Precision Medicine
11/2016
1
Radiotherapy
09/2007
1
Cranial Irradiation
01/2005